135 related articles for article (PubMed ID: 1685667)
1. The effects of selective beta-adrenoceptor antagonists and partial agonist activity on renal function during exercise in normal subjects and those with moderate renal impairment.
Taverner D; Mackay IG; Craig K; Watson ML
Br J Clin Pharmacol; 1991 Sep; 32(3):387-91. PubMed ID: 1685667
[TBL] [Abstract][Full Text] [Related]
2. Intrinsic sympathomimetic activity of cardioselective beta-adrenoceptor blockers and effects on renal function.
Mackay IG; Macnicol AM; Smith HJ; Cumming AD; Watson ML
Br J Clin Pharmacol; 1985 Sep; 20(3):197-203. PubMed ID: 2864052
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacology of epanolol. Pharmacodynamic aspects.
Harry JD
Drugs; 1989; 38 Suppl 2():18-27. PubMed ID: 2575976
[TBL] [Abstract][Full Text] [Related]
4. Modest antihypertensive effect of epanolol, a beta 1-selective receptor blocker with beta 1 agonist activity: an acute and long-term hemodynamic study at rest and during exercise and double crossover comparison with atenolol on ambulatory blood pressure.
Omvik P; Lund-Johansen P; Haugland H
Cardiovasc Drugs Ther; 1993 Feb; 7(1):125-32. PubMed ID: 8097925
[TBL] [Abstract][Full Text] [Related]
5. Immediate haemodynamic effects of a novel partial agonist, beta 1-adrenoceptor blocking drug ICI 141,292 after intravenous administration to healthy young volunteers and patients with ischaemic heart disease.
Bonde J; Svendsen TL; Lyngborg K; Mehlsen J; Trap-Jensen J
Br J Clin Pharmacol; 1987 Jan; 23(1):35-40. PubMed ID: 2880603
[TBL] [Abstract][Full Text] [Related]
6. The pharmacology of epanolol (ICI 141292)--a new beta 1-selective adrenoceptor partial agonist.
Bilski AJ; Hadfield SE; Wale JL
J Cardiovasc Pharmacol; 1988 Aug; 12(2):227-32. PubMed ID: 2459554
[TBL] [Abstract][Full Text] [Related]
7. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of xamoterol, atenolol and propranolol on breathlessness, fatigue and plasma electrolytes during exercise in healthy volunteers.
Sørensen EV; Jensen HK; Faergeman O
Eur J Clin Pharmacol; 1991; 41(1):51-5. PubMed ID: 1685993
[TBL] [Abstract][Full Text] [Related]
9. Effect of beta-adrenoceptor agents on the blood flow in carotid arteries in normal volunteers.
Fitzgerald DE; Harry JD
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):73S-74S. PubMed ID: 2572260
[TBL] [Abstract][Full Text] [Related]
10. The influence of beta-adrenoceptor antagonists with and without partial agonist activity on exercise tolerance and muscle lactate production.
Lees KR; Curzio J; Farish E; Borland WW; Rubin PC
Eur J Clin Pharmacol; 1987; 33(4):415-7. PubMed ID: 2894994
[TBL] [Abstract][Full Text] [Related]
11. Effect of angiotensin II type 1 receptor blocker, candesartan, and beta 1 adrenoceptor blocker, atenolol, on brain damage in ischemic stroke.
Saad MA; Abbas AM; Boshra V; Elkhateeb M; El Aal IA
Acta Physiol Hung; 2010 Jun; 97(2):159-71. PubMed ID: 20511125
[TBL] [Abstract][Full Text] [Related]
12. Effects of beta-adrenoceptor blockade on heart rate and physiological tremor in diabetics with autonomic neuropathy. A comparative study of epanolol, atenolol and pindolol.
Reid W; Ewing DJ; Harry JD; Smith HJ; Neilson JM; Clarke BF
Br J Clin Pharmacol; 1987 Apr; 23(4):383-9. PubMed ID: 2883987
[TBL] [Abstract][Full Text] [Related]
13. Effect of partial agonist activity on the side effects of beta-blockade in patients with chronic stable angina.
Chambers J; Ong ML; Akhras F; Adam G; Jackson G
Drugs; 1989; 38 Suppl 2():39-44. PubMed ID: 2575979
[TBL] [Abstract][Full Text] [Related]
14. The effects of combined angiotensin converting enzyme inhibition and beta-adrenoceptor blockade on plasma renin activity in anaesthetized dogs.
Cambridge D; Whiting MV; Butterfield LJ; Allan G
Br J Pharmacol; 1992 Jun; 106(2):342-7. PubMed ID: 1356560
[TBL] [Abstract][Full Text] [Related]
15. The effects of beta blockade with (epanolol) and without (atenolol) intrinsic sympathomimetic activity in stable angina pectoris. The Visacor Study Group.
Boberg J; Larsen FF; Pehrsson SK
Clin Cardiol; 1992 Aug; 15(8):591-5. PubMed ID: 1354086
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive and hormonal responses to beta-blockade with intrinsic sympathomimetic activity: pindolol versus epanolol.
Simon G; Wittig VJ
J Cardiovasc Pharmacol; 1987 Nov; 10(5):543-7. PubMed ID: 2447403
[TBL] [Abstract][Full Text] [Related]
17. Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.
Gullestad L; Birkeland K; Nordby G; Larsen S; Kjekshus J
Br J Clin Pharmacol; 1991 Aug; 32(2):201-7. PubMed ID: 1681847
[TBL] [Abstract][Full Text] [Related]
18. Beta 1-adrenoceptor selectivity of single oral doses of bisoprolol and atenolol.
Chang PC; van Veen S; van der Krogt JA; Vermeij P; van Brummelen P
J Cardiovasc Pharmacol; 1988 Sep; 12(3):317-22. PubMed ID: 2464104
[TBL] [Abstract][Full Text] [Related]
19. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
McCaffrey PM; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
[TBL] [Abstract][Full Text] [Related]
20. Does beta 1-selective agonistic activity interfere with the antihypertensive efficacy of beta 1-selective blocking agents?
Leonetti G; Sampieri L; Cuspidi C; Terzoli L; Rupoli L; Fruscio M; Gradnik R; Zanchetti A
J Hypertens Suppl; 1985 Dec; 3(3):S243-5. PubMed ID: 2908819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]